PTC Therapeutics, Inc. (PTCT)
USD 43.25
(7.35%)
USD 43.25
(7.35%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 2.72 Billion USD | 32.59% |
| 2022 | 2.05 Billion USD | 5.99% |
| 2021 | 1.93 Billion USD | 12.18% |
| 2020 | 1.72 Billion USD | 67.69% |
| 2019 | 1.02 Billion USD | 33.96% |
| 2018 | 768.49 Million USD | 226.72% |
| 2017 | 235.21 Million USD | 57.06% |
| 2016 | 149.76 Million USD | 115.26% |
| 2015 | 69.57 Million USD | 100.2% |
| 2014 | 34.75 Million USD | 126.24% |
| 2013 | 15.36 Million USD | -52.4% |
| 2012 | 32.26 Million USD | -88.59% |
| 2011 | 282.75 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 2.68 Billion USD | -1.4% |
| 2024 Q2 | 2.89 Billion USD | 7.94% |
| 2023 Q2 | 1.91 Billion USD | -7.21% |
| 2023 Q4 | 2.72 Billion USD | 40.97% |
| 2023 FY | 2.72 Billion USD | 32.59% |
| 2023 Q3 | 1.93 Billion USD | 0.69% |
| 2023 Q1 | 2.06 Billion USD | 0.67% |
| 2022 Q2 | 1.98 Billion USD | 5.08% |
| 2022 Q3 | 1.8 Billion USD | -9.21% |
| 2022 Q4 | 2.05 Billion USD | 13.83% |
| 2022 FY | 2.05 Billion USD | 5.99% |
| 2022 Q1 | 1.89 Billion USD | -2.4% |
| 2021 Q2 | 1.86 Billion USD | 2.35% |
| 2021 Q3 | 1.9 Billion USD | 2.16% |
| 2021 Q1 | 1.81 Billion USD | 5.39% |
| 2021 FY | 1.93 Billion USD | 12.18% |
| 2021 Q4 | 1.93 Billion USD | 1.8% |
| 2020 Q1 | 1.01 Billion USD | -1.22% |
| 2020 Q4 | 1.72 Billion USD | 3.36% |
| 2020 Q3 | 1.67 Billion USD | 84.72% |
| 2020 Q2 | 904.14 Million USD | -11.08% |
| 2020 FY | 1.72 Billion USD | 67.69% |
| 2019 Q4 | 1.02 Billion USD | 5.28% |
| 2019 Q2 | 802.88 Million USD | 4.14% |
| 2019 Q3 | 977.83 Million USD | 21.79% |
| 2019 Q1 | 770.96 Million USD | 0.32% |
| 2019 FY | 1.02 Billion USD | 33.96% |
| 2018 FY | 768.49 Million USD | 226.72% |
| 2018 Q3 | 642.53 Million USD | 162.94% |
| 2018 Q2 | 244.37 Million USD | 6.66% |
| 2018 Q1 | 229.1 Million USD | -2.6% |
| 2018 Q4 | 768.49 Million USD | 19.6% |
| 2017 Q2 | 213.34 Million USD | 44.33% |
| 2017 Q4 | 235.21 Million USD | 6.03% |
| 2017 FY | 235.21 Million USD | 57.06% |
| 2017 Q1 | 147.81 Million USD | -1.3% |
| 2017 Q3 | 221.83 Million USD | 3.98% |
| 2016 Q1 | 139.23 Million USD | 100.12% |
| 2016 FY | 149.76 Million USD | 115.26% |
| 2016 Q4 | 149.76 Million USD | 1.19% |
| 2016 Q3 | 148 Million USD | 5.76% |
| 2016 Q2 | 139.93 Million USD | 0.51% |
| 2015 FY | 69.57 Million USD | 100.2% |
| 2015 Q4 | 69.57 Million USD | -45.2% |
| 2015 Q3 | 126.94 Million USD | 402.95% |
| 2015 Q2 | 25.24 Million USD | -3.66% |
| 2015 Q1 | 26.2 Million USD | -24.61% |
| 2014 Q4 | 34.75 Million USD | 78.22% |
| 2014 FY | 34.75 Million USD | 126.24% |
| 2014 Q1 | 11.49 Million USD | -25.15% |
| 2014 Q3 | 19.49 Million USD | 41.28% |
| 2014 Q2 | 13.8 Million USD | 20.04% |
| 2013 Q3 | 16.21 Million USD | -90.76% |
| 2013 Q4 | 15.36 Million USD | -5.25% |
| 2013 FY | 15.36 Million USD | -52.4% |
| 2013 Q1 | 30.32 Million USD | -6.01% |
| 2013 Q2 | 175.46 Million USD | 478.56% |
| 2012 FY | 32.26 Million USD | -88.59% |
| 2012 Q4 | 32.26 Million USD | 0.0% |
| 2011 FY | 282.75 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Caribou Biosciences, Inc. | 72.56 Million USD | -3650.653% |
| Inhibikase Therapeutics, Inc. | 3.52 Million USD | -77030.862% |
| Alaunos Therapeutics, Inc. | 1.95 Million USD | -139048.057% |
| Viracta Therapeutics, Inc. | 38.37 Million USD | -6992.841% |
| Phathom Pharmaceuticals, Inc. | 486.6 Million USD | -459.336% |
| C4 Therapeutics, Inc. | 130.33 Million USD | -1988.23% |
| Agenus Inc. | 462.29 Million USD | -488.744% |
| Fortress Biotech, Inc. | 165.93 Million USD | -1540.203% |
| GlycoMimetics, Inc. | 6.9 Million USD | -39333.596% |
| Novavax, Inc. | 2.57 Billion USD | -5.811% |
| Keros Therapeutics, Inc. | 37.81 Million USD | -7098.075% |
| Eton Pharmaceuticals, Inc. | 16.26 Million USD | -16635.756% |
| CARGO Therapeutics, Inc. Common Stock | 47.65 Million USD | -5611.933% |
| Entrada Therapeutics, Inc. | 226.83 Million USD | -1099.891% |
| Akebia Therapeutics, Inc. | 272.28 Million USD | -899.584% |
| Alnylam Pharmaceuticals, Inc. | 4.05 Billion USD | 32.805% |
| AlloVir, Inc. | 45.01 Million USD | -5946.287% |
| Aptorum Group Limited | 5.25 Million USD | -51676.139% |
| Ardelyx, Inc. | 130.76 Million USD | -1981.427% |
| Bicycle Therapeutics plc | 224.41 Million USD | -1112.83% |
| BioXcel Therapeutics, Inc. | 130.21 Million USD | -1990.266% |
| Chimerix, Inc. | 19.74 Million USD | -13684.432% |
| Corbus Pharmaceuticals Holdings, Inc. | 35.17 Million USD | -7637.235% |
| CRISPR Therapeutics AG | 346.76 Million USD | -684.887% |
| Clearside Biomedical, Inc. | 49.93 Million USD | -5351.104% |
| Precision BioSciences, Inc. | 140.92 Million USD | -1831.405% |
| Dyadic International, Inc. | 2.34 Million USD | -116181.154% |
| Elevation Oncology, Inc. | 34.28 Million USD | -7839.257% |
| Fortress Biotech, Inc. | 165.93 Million USD | -1540.203% |
| GT Biopharma, Inc. | 6.63 Million USD | -40933.258% |
| Alkermes plc | 933.53 Million USD | -191.551% |
| Immix Biopharma, Inc. | 3.72 Million USD | -73029.895% |
| Innoviva, Inc. | 568.55 Million USD | -378.714% |
| IO Biotech, Inc. | 17.55 Million USD | -15403.167% |
| Jaguar Health, Inc. | 45.86 Million USD | -5834.104% |
| Ligand Pharmaceuticals Incorporated | 130.7 Million USD | -1982.318% |
| ContextLogic Inc. | 206 Million USD | -1221.231% |
| AbCellera Biologics Inc. | 335.77 Million USD | -710.581% |
| Lantern Pharma Inc. | 2.73 Million USD | -99244.96% |
| Kintara Therapeutics, Inc. | 2.44 Million USD | -111218.446% |
| Arrowhead Pharmaceuticals, Inc. | 478.39 Million USD | -468.937% |
| Madrigal Pharmaceuticals, Inc. | 235.21 Million USD | -1057.132% |
| MEI Pharma, Inc. | 8.35 Million USD | -32476.134% |
| Barinthus Biotherapeutics plc | 27.51 Million USD | -9793.265% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -41092.993% |
| Marinus Pharmaceuticals, Inc. | 154.14 Million USD | -1665.721% |
| NextCure, Inc. | 14.99 Million USD | -18048.536% |
| HOOKIPA Pharma Inc. | 71.48 Million USD | -3707.689% |
| ChromaDex Corporation | 26.5 Million USD | -10167.602% |
| IDEAYA Biosciences, Inc. | 28.22 Million USD | -9542.656% |
| Incyte Corporation | 1.59 Billion USD | -70.934% |
| Opthea Limited | 264.6 Million USD | -928.618% |
| MiMedx Group, Inc. | 96.33 Million USD | -2725.429% |
| Outlook Therapeutics, Inc. | 46.73 Million USD | -5723.265% |
| Aadi Bioscience, Inc. | 27.22 Million USD | -9896.092% |
| Psyence Biomedical Ltd. | 12.1 Million USD | -22384.954% |
| Vaxcyte, Inc. | 167.44 Million USD | -1525.412% |
| PDS Biotechnology Corporation | 33.25 Million USD | -8083.424% |
| Pharming Group N.V. | 244.07 Million USD | -1015.132% |
| Pieris Pharmaceuticals, Inc. | 11.92 Million USD | -22729.525% |
| Onconetix, Inc. | 23.18 Million USD | -11641.293% |
| Acelyrin, Inc. | 86.35 Million USD | -3051.872% |
| PureTech Health plc | 125.58 Million USD | -2067.281% |
| Pyxis Oncology, Inc. | 48.02 Million USD | -5567.686% |
| Avidity Biosciences, Inc. | 127.79 Million USD | -2029.834% |
| TransCode Therapeutics, Inc. | 3.52 Million USD | -77027.321% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -41092.993% |
| ESSA Pharma Inc. | 3.49 Million USD | -77773.554% |
| Rigel Pharmaceuticals, Inc. | 145.86 Million USD | -1765.877% |
| Ocuphire Pharma, Inc. | 4.04 Million USD | -67236.368% |
| Seer, Inc. | 39.36 Million USD | -6814.101% |
| Sangamo Therapeutics, Inc. | 82.43 Million USD | -3201.755% |
| SELLAS Life Sciences Group, Inc. | 14.37 Million USD | -18828.549% |
| Sol-Gel Technologies Ltd. | 6.64 Million USD | -40871.489% |
| Salarius Pharmaceuticals, Inc. | 1.29 Million USD | -209386.616% |
| Summit Therapeutics Inc. | 125.25 Million USD | -2072.921% |
| Sensei Biotherapeutics, Inc. | 9.47 Million USD | -28613.324% |
| Senti Biosciences, Inc. | 52.57 Million USD | -5077.257% |
| ImmuCell Corporation | 18.81 Million USD | -14365.758% |
| Syros Pharmaceuticals, Inc. | 151.51 Million USD | -1696.383% |
| Janux Therapeutics, Inc. | 36.05 Million USD | -7448.217% |
| Precigen, Inc. | 41.64 Million USD | -6435.722% |
| Longboard Pharmaceuticals, Inc. | 9.77 Million USD | -27746.695% |
| Oncternal Therapeutics, Inc. | 6.67 Million USD | -40662.858% |
| Stoke Therapeutics, Inc. | 68.77 Million USD | -3857.335% |
| Xeris Biopharma Holdings, Inc. | 347.58 Million USD | -683.053% |
| Telomir Pharmaceuticals, Inc. Common Stock | 1.33 Million USD | -203689.261% |
| Sorrento Therapeutics, Inc. | 494.5 Million USD | -450.392% |
| Verrica Pharmaceuticals Inc. | 61.83 Million USD | -4301.682% |
| VistaGen Therapeutics, Inc. | 9.36 Million USD | -28956.646% |
| VYNE Therapeutics Inc. | 8.95 Million USD | -30310.458% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | -9280.445% |
| Wave Life Sciences Ltd. | 227.44 Million USD | -1096.657% |
| Fate Therapeutics, Inc. | 137.8 Million USD | -1875.135% |
| TRACON Pharmaceuticals, Inc. | 10.91 Million USD | -24838.025% |
| Inhibrx Biosciences, Inc. | 264.39 Million USD | -929.44% |
| Catalyst Pharmaceuticals, Inc. | 84.02 Million USD | -3139.159% |
| Orchestra BioMed Holdings, Inc. | 27.16 Million USD | -9917.8% |
| Alzamend Neuro, Inc. | 3.22 Million USD | -84274.691% |
| Rocket Pharmaceuticals, Inc. | 73.76 Million USD | -3589.639% |
| Aptose Biosciences Inc. | 15.8 Million USD | -17116.696% |
| ZyVersa Therapeutics, Inc. | 11.03 Million USD | -24554.107% |
| Soligenix, Inc. | 7.27 Million USD | -37312.672% |
| Century Therapeutics, Inc. | 175.94 Million USD | -1446.959% |
| Kura Oncology, Inc. | 51.66 Million USD | -5168.352% |
| TScan Therapeutics, Inc. | 121.28 Million USD | -2144.138% |
| Intensity Therapeutics, Inc. | 4.13 Million USD | -65753.762% |
| Ocean Biomedical, Inc. | 6.61 Million USD | -41052.036% |
| CytomX Therapeutics, Inc. | 252.59 Million USD | -977.497% |
| Autolus Therapeutics plc | 263.9 Million USD | -931.324% |
| Mineralys Therapeutics, Inc. | 10.48 Million USD | -25865.808% |
| EyePoint Pharmaceuticals, Inc. | 88.86 Million USD | -2962.914% |
| Eterna Therapeutics Inc. | 46.89 Million USD | -5703.399% |
| Adaptive Biotechnologies Corporation | 352.85 Million USD | -671.345% |
| GRI Bio, Inc. | 2.69 Million USD | -100817.167% |
| Xenetic Biosciences, Inc. | 809.58 Thousand USD | -336089.035% |
| Tenaya Therapeutics, Inc. | 31.09 Million USD | -8654.096% |
| IGM Biosciences, Inc. | 220.17 Million USD | -1136.158% |
| INmune Bio, Inc. | 18.86 Million USD | -14329.732% |
| Heron Therapeutics, Inc. | 256.47 Million USD | -961.193% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -10116.032% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -100022.498% |
| Entero Therapeutics, Inc. | 3.28 Million USD | -82873.027% |
| Milestone Pharmaceuticals Inc. | 58.45 Million USD | -4556.122% |
| X4 Pharmaceuticals, Inc. | 96.15 Million USD | -2730.454% |
| Atara Biotherapeutics, Inc. | 264.73 Million USD | -928.098% |
| Coherus BioSciences, Inc. | 823.02 Million USD | -230.697% |
| Verastem, Inc. | 71.18 Million USD | -3723.468% |
| Abeona Therapeutics Inc. | 49.17 Million USD | -5434.684% |
| Pliant Therapeutics, Inc. | 38.57 Million USD | -6955.151% |
| Tonix Pharmaceuticals Holding Corp. | 48.93 Million USD | -5462.282% |
| Histogen Inc. | 5.69 Million USD | -47674.899% |
| Aprea Therapeutics, Inc. | 4.38 Million USD | -61960.673% |
| Surrozen, Inc. | 8.14 Million USD | -33316.034% |
| Organovo Holdings, Inc. | 2.74 Million USD | -98944.25% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -867087.072% |
| Ovid Therapeutics Inc. | 56.22 Million USD | -4740.372% |
| Panbela Therapeutics, Inc. | 16.51 Million USD | -16383.382% |
| CASI Pharmaceuticals, Inc. | 51.1 Million USD | -5225.981% |
| Cadrenal Therapeutics, Inc. Common Stock | 826.87 Thousand USD | -329059.305% |
| Centessa Pharmaceuticals plc | 126.72 Million USD | -2047.75% |
| Hepion Pharmaceuticals, Inc. | 10.81 Million USD | -25069.588% |
| Arcturus Therapeutics Holdings Inc. | 150.88 Million USD | -1703.8% |
| BioRestorative Therapies, Inc. | 2.6 Million USD | -104287.26% |
| Apollomics, Inc. | 14.15 Million USD | -19130.806% |
| Amarin Corporation plc | 279.58 Million USD | -873.484% |
| Mesoblast Limited | 188.79 Million USD | -1341.613% |
| Turnstone Biologics Corp. | 14.14 Million USD | -19137.602% |
| Kymera Therapeutics, Inc. | 180.78 Million USD | -1405.485% |
| Synaptogenix, Inc. | 5.52 Million USD | -49122.376% |
| Tiziana Life Sciences Ltd | 6.64 Million USD | -40840.674% |
| Aurinia Pharmaceuticals Inc. | 170.1 Million USD | -1500.005% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -31706.411% |
| Monopar Therapeutics Inc. | 1.75 Million USD | -154773.497% |
| Exelixis, Inc. | 678.44 Million USD | -301.173% |
| Better Therapeutics, Inc. | 23.84 Million USD | -11315.72% |
| Nurix Therapeutics, Inc. | 164.04 Million USD | -1559.13% |
| Apellis Pharmaceuticals, Inc. | 594.2 Million USD | -358.044% |
| NLS Pharmaceutics AG | 10.68 Million USD | -25383.933% |
| Dermata Therapeutics, Inc. | 1.62 Million USD | -167534.219% |
| Aridis Pharmaceuticals, Inc. | 38.92 Million USD | -6891.898% |
| Gritstone bio, Inc. | 125.91 Million USD | -2061.497% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -18445.489% |
| TNF Pharmaceuticals, Inc. | 5.08 Million USD | -53386.648% |
| Avid Bioservices, Inc. | 275.66 Million USD | -887.324% |
| Insmed Incorporated | 1.66 Billion USD | -63.786% |
| Virpax Pharmaceuticals, Inc. | 7.69 Million USD | -35274.675% |
| MediWound Ltd. | 27.18 Million USD | -9911.167% |
| OmniAb, Inc. | 87.4 Million USD | -3014.114% |
| Alector, Inc. | 487.66 Million USD | -458.111% |
| Seres Therapeutics, Inc. | 403.45 Million USD | -574.605% |
| Checkpoint Therapeutics, Inc. | 18.42 Million USD | -14671.973% |
| Zai Lab Limited | 240.17 Million USD | -1033.221% |
| Revance Therapeutics, Inc. | 630.05 Million USD | -331.982% |
| Aura Biosciences, Inc. | 29.22 Million USD | -9212.403% |
| Lyell Immunopharma, Inc. | 95.07 Million USD | -2762.665% |
| Immunic, Inc. | 25.36 Million USD | -10629.013% |
| Tarsus Pharmaceuticals, Inc. | 69.23 Million USD | -3831.099% |
| Veracyte, Inc. | 93.71 Million USD | -2804.145% |
| InMed Pharmaceuticals Inc. | 2.61 Million USD | -103915.137% |
| FibroGen, Inc. | 585.72 Million USD | -364.676% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -15557.458% |
| Adial Pharmaceuticals, Inc. | 653.07 Thousand USD | -416656.396% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.65 Million USD | -48025.828% |
| Jazz Pharmaceuticals plc | 7.65 Billion USD | 64.451% |
| Cyclacel Pharmaceuticals, Inc. | 8.19 Million USD | -33100.0% |
| Amylyx Pharmaceuticals, Inc. | 84.02 Million USD | -3139.314% |
| TG Therapeutics, Inc. | 169.08 Million USD | -1509.685% |
| Galecto, Inc. | 5.89 Million USD | -46062.415% |
| Calithera Biosciences, Inc. | 8.28 Million USD | -32755.336% |
| Fortrea Holdings Inc. | 2.61 Billion USD | -3.947% |
| KalVista Pharmaceuticals, Inc. | 28.82 Million USD | -9343.259% |
| Aptevo Therapeutics Inc. | 12.62 Million USD | -21465.137% |
| XBiotech Inc. | 8.39 Million USD | -32313.195% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -18445.489% |
| Lyra Therapeutics, Inc. | 53.18 Million USD | -5017.969% |
| Foghorn Therapeutics Inc. | 363.1 Million USD | -649.571% |
| Y-mAbs Therapeutics, Inc. | 26.88 Million USD | -10023.999% |
| Theravance Biopharma, Inc. | 169 Million USD | -1510.457% |
| Ultragenyx Pharmaceutical Inc. | 1.21 Billion USD | -123.901% |
| Metagenomi, Inc. Common Stock | 500.42 Million USD | -443.884% |
| Vaxxinity, Inc. | 30.94 Million USD | -8695.683% |
| BioCryst Pharmaceuticals, Inc. | 972.48 Million USD | -179.873% |
| Gain Therapeutics, Inc. | 6.03 Million USD | -45028.299% |
| Cartesian Therapeutics, Inc. | 745.23 Million USD | -265.219% |
| NexImmune, Inc. | 5.08 Million USD | -53432.884% |
| Creative Medical Technology Holdings, Inc. | 371.39 Thousand USD | -732743.288% |
| Marker Therapeutics, Inc. | 3.07 Million USD | -88416.115% |
| Regeneron Pharmaceuticals, Inc. | 7.1 Billion USD | 61.704% |
| Chemomab Therapeutics Ltd. | 5.15 Million USD | -52707.919% |
| Scopus BioPharma Inc. | 7.45 Million USD | -36411.639% |
| RAPT Therapeutics, Inc. | 26.29 Million USD | -10251.168% |
| Ainos, Inc. | 7.39 Million USD | -36708.952% |
| Pluri Inc. | 34.11 Million USD | -7878.823% |
| Prothena Corporation plc | 135.01 Million USD | -1915.847% |
| Adaptimmune Therapeutics plc | 243.1 Million USD | -1019.581% |
| Celularity Inc. | 102.92 Million USD | -2544.285% |
| Rallybio Corporation | 9.43 Million USD | -28744.171% |
| Cue Biopharma, Inc. | 24.44 Million USD | -11034.121% |
| MeiraGTx Holdings plc | 319.99 Million USD | -750.566% |
| Omeros Corporation | 403.25 Million USD | -574.947% |
| Humacyte, Inc. | 114.67 Million USD | -2273.393% |
| Immunocore Holdings plc | 228.15 Million USD | -1092.917% |
| Cocrystal Pharma, Inc. | 4.87 Million USD | -55730.482% |
| Cidara Therapeutics, Inc. | 76.74 Million USD | -3446.698% |
| Blueprint Medicines Corporation | 918.64 Million USD | -196.279% |
| CalciMedica, Inc. | 4.02 Million USD | -67470.407% |
| Cabaletta Bio, Inc. | 17.45 Million USD | -15495.554% |
| Scholar Rock Holding Corporation | 85.81 Million USD | -3071.558% |
| Sana Biotechnology, Inc. | 277.79 Million USD | -879.771% |
| Pulmatrix, Inc. | 15.96 Million USD | -16950.279% |
| Elicio Therapeutics, Inc. | 15.77 Million USD | -17155.665% |
| Vigil Neuroscience, Inc. | 24.6 Million USD | -10961.27% |
| Intellia Therapeutics, Inc. | 250.8 Million USD | -985.187% |
| Adlai Nortye Ltd. American Depositary Shares | 50.78 Million USD | -5259.224% |
| Cytokinetics, Incorporated | 1.21 Billion USD | -124.818% |
| Eloxx Pharmaceuticals, Inc. | 31.78 Million USD | -8463.496% |
| Nutriband Inc. | 1.07 Million USD | -252165.091% |
| Protara Therapeutics, Inc. | 10.63 Million USD | -25497.066% |
| Vor Biopharma Inc. | 59.1 Million USD | -4504.995% |
| Roivant Sciences Ltd. | 773.95 Million USD | -251.667% |
| Evogene Ltd. | 17.99 Million USD | -15029.161% |
| ProKidney Corp. | 29.21 Million USD | -9215.909% |
| Applied Therapeutics, Inc. | 71.97 Million USD | -3681.292% |
| Hoth Therapeutics, Inc. | 704.98 Thousand USD | -385971.153% |
| BridgeBio Pharma, Inc. | 1.88 Billion USD | -44.09% |
| CorMedix Inc. | 11.91 Million USD | -22738.092% |
| BioLineRx Ltd. | 50.7 Million USD | -5268.104% |
| Tango Therapeutics, Inc. | 149.45 Million USD | -1721.059% |
| Galectin Therapeutics Inc. | 88.44 Million USD | -2977.46% |
| Atai Life Sciences N.V. | 49.16 Million USD | -5436.26% |
| Renovaro Biosciences Inc. | 31.15 Million USD | -8636.868% |
| Aerovate Therapeutics, Inc. | 17.96 Million USD | -15052.745% |
| Zentalis Pharmaceuticals, Inc. | 124.63 Million USD | -2083.748% |
| Sagimet Biosciences Inc. | 5.65 Million USD | -48038.238% |
| MediciNova, Inc. | 3.89 Million USD | -69839.585% |
| Praxis Precision Medicines, Inc. | 18.27 Million USD | -14789.961% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -180837.496% |
| GeoVax Labs, Inc. | 3.51 Million USD | -77224.66% |
| Axsome Therapeutics, Inc. | 397.25 Million USD | -585.129% |
| Biomea Fusion, Inc. | 30.69 Million USD | -8768.478% |
| Mereo BioPharma Group plc | 15.96 Million USD | -16951.347% |
| Cullinan Oncology, Inc. | 31.2 Million USD | -8623.233% |
| Syndax Pharmaceuticals, Inc. | 58.68 Million USD | -4537.952% |
| Absci Corporation | 58.3 Million USD | -4568.181% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -14188.828% |
| 4D Molecular Therapeutics, Inc. | 32.06 Million USD | -8388.978% |
| Dyne Therapeutics, Inc. | 73.79 Million USD | -3588.489% |
| Kiniksa Pharmaceuticals, Ltd. | 87.48 Million USD | -3011.16% |
| Ventyx Biosciences, Inc. | 33.77 Million USD | -7959.627% |
| Allakos Inc. | 74.79 Million USD | -3539.025% |
| Imunon, Inc. | 8.53 Million USD | -31806.211% |
| Fulcrum Therapeutics, Inc. | 22.5 Million USD | -11996.067% |
| Corcept Therapeutics Incorporated | 114.81 Million USD | -2270.602% |
| BioAtla, Inc. | 48.98 Million USD | -5456.151% |
| NLS Pharmaceutics AG | 10.68 Million USD | -25383.933% |
| Bio-Path Holdings, Inc. | 2.77 Million USD | -97839.403% |
| Allogene Therapeutics, Inc. | 130.6 Million USD | -1983.961% |
| Larimar Therapeutics, Inc. | 14.21 Million USD | -19046.929% |
| XOMA Corporation | 145.58 Million USD | -1769.581% |
| Kezar Life Sciences, Inc. | 33.66 Million USD | -7984.765% |
| Cara Therapeutics, Inc. | 68.75 Million USD | -3858.371% |
| aTyr Pharma, Inc. | 31.59 Million USD | -8513.906% |
| Aligos Therapeutics, Inc. | 61.82 Million USD | -4302.465% |
| Akero Therapeutics, Inc. | 44.96 Million USD | -5953.01% |
| Viridian Therapeutics, Inc. | 48.4 Million USD | -5523.189% |
| Eliem Therapeutics, Inc. | 2.87 Million USD | -94734.007% |
| EyeGate Pharmaceuticals, Inc. | 8.15 Million USD | -33262.711% |
| Akari Therapeutics, Plc | 4.58 Million USD | -59274.695% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -15248.311% |
| Halozyme Therapeutics, Inc. | 1.64 Billion USD | -65.007% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -673750.481% |
| UroGen Pharma Ltd. | 243.52 Million USD | -1017.65% |
| Sutro Biopharma, Inc. | 321.08 Million USD | -747.663% |
| ZIVO Bioscience, Inc. | 2.76 Million USD | -98457.988% |
| Orgenesis Inc. | 35.53 Million USD | -7559.311% |
| Entera Bio Ltd. | 1.37 Million USD | -197270.268% |
| GH Research PLC | 6.7 Million USD | -40516.863% |
| Lisata Therapeutics, Inc. | 6.8 Million USD | -39925.529% |
| Reneo Pharmaceuticals, Inc. | 18.82 Million USD | -14357.325% |
| Xencor, Inc. | 283.55 Million USD | -859.848% |
| 60 Degrees Pharmaceuticals, Inc. | 2.98 Million USD | -91059.821% |
| Replimune Group, Inc. | 113.21 Million USD | -2304.063% |
| Coeptis Therapeutics Holdings, Inc. | 3.75 Million USD | -72341.987% |
| Vanda Pharmaceuticals Inc. | 103.53 Million USD | -2528.935% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -673750.481% |
| Portage Biotech Inc. | 4.45 Million USD | -61062.607% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -180837.496% |
| Olema Pharmaceuticals, Inc. | 23.05 Million USD | -11707.965% |
| OncoCyte Corporation | 49.29 Million USD | -5420.987% |
| Qualigen Therapeutics, Inc. | 4.13 Million USD | -65693.191% |
| Processa Pharmaceuticals, Inc. | 797.48 Thousand USD | -341190.358% |
| Purple Biotech Ltd. | 10 Million USD | -27103.758% |
| CollPlant Biotechnologies Ltd. | 5.78 Million USD | -46940.028% |
| scPharmaceuticals Inc. | 57.26 Million USD | -4653.211% |
| ProMIS Neurosciences, Inc. | 12.38 Million USD | -21870.709% |
| HilleVax, Inc. | 78.9 Million USD | -3349.209% |
| NeuroSense Therapeutics Ltd. | 5.05 Million USD | -53795.762% |
| Tharimmune, Inc. | 1.81 Million USD | -149854.106% |
| Genprex, Inc. | 3.25 Million USD | -83537.432% |
| Neumora Therapeutics, Inc. Common Stock | 27.11 Million USD | -9936.27% |
| Atossa Therapeutics, Inc. | 5.23 Million USD | -51881.207% |
| XTL Biopharmaceuticals Ltd. | 206 Thousand USD | -1321131.068% |
| Virios Therapeutics, Inc. | 358.54 Thousand USD | -758999.479% |
| OKYO Pharma Limited | 7.42 Million USD | -36576.896% |
| Savara Inc. | 37.19 Million USD | -7218.068% |
| Curis, Inc. | 57.61 Million USD | -4624.252% |
| Daré Bioscience, Inc. | 26.32 Million USD | -10237.072% |
| Carmell Therapeutics Corporation | 39.19 Million USD | -6843.241% |
| Titan Pharmaceuticals, Inc. | 1.44 Million USD | -188385.873% |
| Achieve Life Sciences, Inc. | 20.81 Million USD | -12973.327% |
| BeiGene, Ltd. | 2.23 Billion USD | -21.846% |
| Kiromic BioPharma, Inc. | 21.28 Million USD | -12684.225% |
| Revolution Medicines, Inc. Warrant | 262.39 Million USD | -937.259% |
| Protagonist Therapeutics, Inc. | 21.27 Million USD | -12693.72% |
| Erasca, Inc. | 78.61 Million USD | -3362.284% |
| bluebird bio, Inc. | 424.62 Million USD | -540.976% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -415272.406% |
| BioMarin Pharmaceutical Inc. | 1.89 Billion USD | -44.003% |
| DBV Technologies S.A. | 42.8 Million USD | -6259.196% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -415272.406% |
| Moderna, Inc. | 4.57 Billion USD | 40.469% |
| Vincerx Pharma, Inc. | 6.99 Million USD | -38809.736% |
| Fresh Tracks Therapeutics, Inc. | 1.65 Million USD | -164256.039% |
| Molecular Templates, Inc. | 31.17 Million USD | -8631.629% |
| Acrivon Therapeutics, Inc. Common Stock | 17.07 Million USD | -15844.558% |
| Travere Therapeutics, Inc. | 588.1 Million USD | -362.799% |
| Monte Rosa Therapeutics, Inc. | 124.5 Million USD | -2086.046% |
| Spruce Biosciences, Inc. | 27.43 Million USD | -9819.948% |
| Celldex Therapeutics, Inc. | 36.45 Million USD | -7365.811% |
| Cogent Biosciences, Inc. | 55.63 Million USD | -4792.129% |
| MacroGenics, Inc. | 154.2 Million USD | -1664.989% |
| RenovoRx, Inc. | 4.46 Million USD | -60843.484% |
| Adicet Bio, Inc. | 37.12 Million USD | -7232.263% |
| Prime Medicine, Inc. | 60.78 Million USD | -4378.013% |
| Aditxt, Inc. | 28.53 Million USD | -9439.388% |
| Adagene Inc. | 45.16 Million USD | -5925.627% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -1506109.706% |
| Quantum-Si incorporated | 26.63 Million USD | -10120.179% |
| Maravai LifeSciences Holdings, Inc. | 697.56 Million USD | -290.176% |
| Acurx Pharmaceuticals, Inc. | 3.04 Million USD | -89359.046% |
| Voyager Therapeutics, Inc. | 114.96 Million USD | -2267.53% |
| SciSparc Ltd. | 1.59 Million USD | -170541.755% |
| Vericel Corporation | 127.7 Million USD | -2031.268% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -48809.036% |
| Minerva Neurosciences, Inc. | 85.35 Million USD | -3088.609% |
| Generation Bio Co. | 171.63 Million USD | -1485.816% |
| Astria Therapeutics, Inc. | 11.55 Million USD | -23464.814% |
| Black Diamond Therapeutics, Inc. | 41.83 Million USD | -6406.505% |
| Arcutis Biotherapeutics, Inc. | 252.69 Million USD | -977.071% |
| Invivyd, Inc. | 51.71 Million USD | -5163.156% |
| Relay Therapeutics, Inc. | 91.97 Million USD | -2859.148% |
| Quoin Pharmaceuticals, Ltd. | 6.5 Million USD | -41739.062% |
| Spero Therapeutics, Inc. | 75.49 Million USD | -3505.139% |
| Artelo Biosciences, Inc. | 1.02 Million USD | -266475.514% |
| 2seventy bio, Inc. | 310.12 Million USD | -777.623% |
| ADMA Biologics, Inc. | 193.97 Million USD | -1303.13% |
| Clene Inc. | 38.95 Million USD | -6887.59% |
| Capricor Therapeutics, Inc. | 36.13 Million USD | -7432.578% |
| Boundless Bio, Inc. Common Stock | 256.97 Million USD | -959.14% |
| GeoVax Labs, Inc. | 3.51 Million USD | -77224.66% |
| Recursion Pharmaceuticals, Inc. | 190.26 Million USD | -1330.513% |
| Citius Pharmaceuticals, Inc. | 12.17 Million USD | -22246.564% |
| Contineum Therapeutics, Inc. Class A Common Stock | 198.32 Million USD | -1272.382% |
| Relmada Therapeutics, Inc. | 12.19 Million USD | -22218.824% |
| Finch Therapeutics Group, Inc. | 48.11 Million USD | -5557.201% |
| ALX Oncology Holdings Inc. | 52.84 Million USD | -5050.803% |
| Vir Biotechnology, Inc. | 369.85 Million USD | -635.895% |
| Evaxion Biotech A/S | 17.61 Million USD | -15349.065% |
| Ocular Therapeutix, Inc. | 160.92 Million USD | -1591.265% |
| Verve Therapeutics, Inc. | 153.18 Million USD | -1676.752% |
| Trevena, Inc. | 48.26 Million USD | -5539.501% |
| Surrozen, Inc. | 8.14 Million USD | -33316.034% |
| Tyra Biosciences, Inc. | 21.59 Million USD | -12503.547% |
| Cingulate Inc. | 10.36 Million USD | -26169.39% |
| Galmed Pharmaceuticals Ltd. | 2.75 Million USD | -98872.218% |
| Unity Biotechnology, Inc. | 37.29 Million USD | -7198.445% |
| Tenax Therapeutics, Inc. | 3.58 Million USD | -75787.936% |
| Terns Pharmaceuticals, Inc. | 13.15 Million USD | -20597.612% |
| ACADIA Pharmaceuticals Inc. | 317.2 Million USD | -758.048% |
| Connect Biopharma Holdings Limited | 24.84 Million USD | -10853.101% |
| Clearmind Medicine Inc. | 3.61 Million USD | -75294.182% |
| Kronos Bio, Inc. | 54.2 Million USD | -4921.56% |
| Bolt Biotherapeutics, Inc. | 47.04 Million USD | -5685.634% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -11858.559% |
| Viking Therapeutics, Inc. | 20.07 Million USD | -13460.54% |
| Statera Biopharma, Inc. | 22.67 Million USD | -11902.477% |
| ImmunityBio, Inc. | 1.09 Billion USD | -149.611% |
| Korro Bio, Inc. | 51.75 Million USD | -5159.19% |
| Kineta, Inc. | 7.22 Million USD | -37586.735% |
| BioVie Inc. | 9.7 Million USD | -27952.974% |
| Codexis, Inc. | 49.94 Million USD | -5349.357% |
| Celularity Inc. | 102.92 Million USD | -2544.285% |
| Crinetics Pharmaceuticals, Inc. | 96.24 Million USD | -2727.866% |
| Celcuity Inc. | 51.45 Million USD | -5190.052% |
| Virax Biolabs Group Limited | 345.19 Thousand USD | -788365.616% |
| Cibus, Inc. | 206.11 Million USD | -1220.481% |
| Eledon Pharmaceuticals, Inc. | 42.47 Million USD | -6307.854% |
| eFFECTOR Therapeutics, Inc. | 26.33 Million USD | -10233.483% |
| IN8bio, Inc. | 8.77 Million USD | -30927.542% |
| Kodiak Sciences Inc. | 213.59 Million USD | -1174.275% |
| Annexon, Inc. | 47.11 Million USD | -5676.425% |
| Adverum Biotechnologies, Inc. | 89.54 Million USD | -2939.653% |
| Assembly Biosciences, Inc. | 96.37 Million USD | -2724.198% |
| Avalo Therapeutics, Inc. | 13.68 Million USD | -19782.65% |
| Ionis Pharmaceuticals, Inc. | 2.6 Billion USD | -4.546% |
| Eyenovia, Inc. | 19.78 Million USD | -13659.846% |
| Puma Biotechnology, Inc. | 177.08 Million USD | -1436.957% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -35334.657% |
| Xilio Therapeutics, Inc. | 24.09 Million USD | -11193.979% |
| Arcellx, Inc. | 339.75 Million USD | -701.095% |
| Cardiff Oncology, Inc. | 11.89 Million USD | -22775.576% |
| Enanta Pharmaceuticals, Inc. | 245.54 Million USD | -1008.469% |
| Regulus Therapeutics Inc. | 9.56 Million USD | -28361.111% |
| Moolec Science SA | 13.94 Million USD | -19417.15% |
| Acumen Pharmaceuticals, Inc. | 43.15 Million USD | -6207.323% |
| Geron Corporation | 146.12 Million USD | -1762.583% |
| LAVA Therapeutics N.V. | 50.53 Million USD | -5286.163% |
| Royalty Pharma plc | 6.29 Billion USD | 56.781% |
| Atea Pharmaceuticals, Inc. | 39.77 Million USD | -6742.659% |
| Greenwich LifeSciences, Inc. | 294.4 Thousand USD | -924383.876% |
| TFF Pharmaceuticals, Inc. | 2.46 Million USD | -110526.993% |
| Mersana Therapeutics, Inc. | 189.15 Million USD | -1338.884% |
| Humacyte, Inc. | 114.67 Million USD | -2273.393% |
| Structure Therapeutics Inc. | 29.05 Million USD | -9268.819% |
| 89bio, Inc. | 59.96 Million USD | -4439.026% |
| PMV Pharmaceuticals, Inc. | 26.46 Million USD | -10185.062% |
| Avenue Therapeutics, Inc. | 1.19 Million USD | -227469.9% |
| Genelux Corporation | 8.42 Million USD | -32224.656% |
| Trevi Therapeutics, Inc. | 6.85 Million USD | -39598.6% |
| Lexicon Pharmaceuticals, Inc. | 136.31 Million USD | -1896.593% |
| Notable Labs, Ltd. | 4.42 Million USD | -61380.37% |
| Liquidia Corporation | 73.13 Million USD | -3621.371% |
| Mustang Bio, Inc. | 17.61 Million USD | -15347.733% |
| Immunovant, Inc. | 48.95 Million USD | -5459.669% |
| Quantum-Si incorporated | 26.63 Million USD | -10120.179% |
| Arbutus Biopharma Corporation | 38.38 Million USD | -6990.993% |
| DiaMedica Therapeutics Inc. | 3.1 Million USD | -87613.052% |
| Vera Therapeutics, Inc. | 73.86 Million USD | -3584.943% |
| Acasti Pharma Inc. | 11.55 Million USD | -23450.541% |
| MiNK Therapeutics, Inc. | 22.6 Million USD | -11938.962% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -100022.498% |
| Xenon Pharmaceuticals Inc. | 36.87 Million USD | -7280.579% |
| Elevai Labs, Inc. Common Stock | 1.36 Million USD | -199610.311% |
| NeuroBo Pharmaceuticals, Inc. | 6.09 Million USD | -44547.9% |
| Tempest Therapeutics, Inc. | 24.83 Million USD | -10859.275% |
| Soleno Therapeutics, Inc. | 23.18 Million USD | -11639.717% |
| PepGen Inc. | 34.63 Million USD | -7759.247% |
| Moleculin Biotech, Inc. | 12.14 Million USD | -22312.187% |
| United Therapeutics Corporation | 1.18 Billion USD | -130.226% |
| Nuvectis Pharma, Inc. | 6.98 Million USD | -38871.019% |
| Solid Biosciences Inc. | 38.45 Million USD | -6977.165% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -31706.411% |
| Immuneering Corporation | 12 Million USD | -22565.353% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -867087.072% |
| Silo Pharma, Inc. | 1.56 Million USD | -173339.625% |
| Belite Bio, Inc | 4.21 Million USD | -64533.959% |
| XOMA Corporation | 145.58 Million USD | -1769.581% |
| ARS Pharmaceuticals, Inc. | 2.42 Million USD | -111997.858% |
| Bionomics Limited | 10.15 Million USD | -26692.113% |
| Apogee Therapeutics, Inc. | 21.49 Million USD | -12564.539% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -11778.567% |
| uniQure N.V. | 624.01 Million USD | -336.162% |
| Cassava Sciences, Inc. | 14.19 Million USD | -19073.906% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -1506109.706% |
| Poseida Therapeutics, Inc. | 170.18 Million USD | -1499.29% |
| Forte Biosciences, Inc. | 3.66 Million USD | -74142.662% |
| Anebulo Pharmaceuticals, Inc. | 260.58 Thousand USD | -1044379.494% |
| Enlivex Therapeutics Ltd. | 6.74 Million USD | -40239.944% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -35334.657% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -15557.458% |
| FibroBiologics, Inc. Common Stock | 10.56 Million USD | -25654.504% |
| Altimmune, Inc. | 16.54 Million USD | -16354.483% |
| Amicus Therapeutics, Inc. | 617.7 Million USD | -340.62% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -11778.567% |
| Compugen Ltd. | 55.77 Million USD | -4779.849% |
| Peak Bio, Inc. | 20.75 Million USD | -13014.674% |
| Zevra Therapeutics, Inc. | 110.46 Million USD | -2363.935% |
| Benitec Biopharma Inc. | 4.96 Million USD | -54751.592% |
| Spyre Therapeutics, Inc. | 157.84 Million USD | -1624.331% |
| NKGen Biotech, Inc. Common Stock | 75.17 Million USD | -3520.582% |
| Zura Bio Limited | 21.29 Million USD | -12682.904% |
| PolyPid Ltd. | 17.46 Million USD | -15481.269% |
| Aileron Therapeutics, Inc. | 112.39 Million USD | -2321.495% |
| NKGen Biotech, Inc. Warrants | 75.17 Million USD | -3520.582% |
| Instil Bio, Inc. | 99.8 Million USD | -2627.163% |
| argenx SE | 444.95 Million USD | -511.693% |
| Immunome, Inc. | 28.65 Million USD | -9397.299% |
| Compass Therapeutics, Inc. | 8.33 Million USD | -32546.468% |
| Verona Pharma plc | 58.84 Million USD | -4525.577% |
| enGene Holdings Inc. Warrants | 14.47 Million USD | -18705.61% |
| Shattuck Labs, Inc. | 14.85 Million USD | -18217.087% |
| CervoMed Inc. | 2.59 Million USD | -104753.67% |
| LENZ Therapeutics, Inc. | 4.87 Million USD | -55741.937% |
| Plus Therapeutics, Inc. | 12.73 Million USD | -21270.415% |
| Dianthus Therapeutics, Inc. | 10.53 Million USD | -25735.178% |
| Moolec Science SA | 13.94 Million USD | -19417.15% |
| Enveric Biosciences, Inc. | 2.34 Million USD | -116039.593% |
| Inovio Pharmaceuticals, Inc. | 55.59 Million USD | -4795.623% |
| AnaptysBio, Inc. | 364.28 Million USD | -647.143% |
| Design Therapeutics, Inc. | 11.95 Million USD | -22664.604% |
| Leap Therapeutics, Inc. | 12.68 Million USD | -21358.026% |
| NeurAxis, Inc. | 1.91 Million USD | -142195.211% |
| Seelos Therapeutics, Inc. | 38.92 Million USD | -6891.718% |
| Lumos Pharma, Inc. | 13.33 Million USD | -20313.53% |
| Achilles Therapeutics plc | 19.08 Million USD | -14159.632% |
| enGene Holdings Inc. Common Stock | 14.47 Million USD | -18705.61% |
| 180 Life Sciences Corp. | 5.38 Million USD | -50422.191% |
| Opiant Pharmaceuticals, Inc. | 23.58 Million USD | -11438.652% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -11858.559% |
| Nutriband Inc. | 1.07 Million USD | -252165.091% |
| ORIC Pharmaceuticals, Inc. | 30.59 Million USD | -8795.143% |
| CG Oncology, Inc. Common stock | 14.51 Million USD | -18656.364% |
| Fractyl Health, Inc. Common Stock | 401.27 Million USD | -578.274% |
| Rani Therapeutics Holdings, Inc. | 32.47 Million USD | -8281.535% |
| MoonLake Immunotherapeutics | 13.04 Million USD | -20757.659% |
| Palisade Bio, Inc. | 2.73 Million USD | -99269.697% |
| Tourmaline Bio, Inc. | 5.25 Million USD | -51712.983% |
| Beam Therapeutics Inc. | 478.38 Million USD | -468.943% |
| Neurogene Inc. | 36.54 Million USD | -7346.814% |
| Mirum Pharmaceuticals, Inc. | 397.95 Million USD | -583.937% |
| AEON Biopharma, Inc. | 159.88 Million USD | -1602.266% |
| Sesen Bio, Inc. | 30.98 Million USD | -8684.327% |
| Enliven Therapeutics, Inc. | 25.96 Million USD | -10383.941% |
| Kiora Pharmaceuticals, Inc. | 7.6 Million USD | -35701.877% |
| Iovance Biotherapeutics, Inc. | 195.73 Million USD | -1290.5% |
| Taysha Gene Therapies, Inc. | 192.05 Million USD | -1317.15% |
| Athira Pharma, Inc. | 30.05 Million USD | -8955.248% |
| Vaccinex, Inc. | 5.94 Million USD | -45705.049% |
| HCW Biologics Inc. | 15.05 Million USD | -17982.29% |
| XOMA Corporation | 145.58 Million USD | -1769.581% |
| Nektar Therapeutics | 267.04 Million USD | -919.201% |
| Arvinas, Inc. | 644.6 Million USD | -322.236% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -15248.311% |
| Merus N.V. | 102.15 Million USD | -2564.424% |
| Omega Therapeutics, Inc. | 146.35 Million USD | -1759.744% |
| Quince Therapeutics, Inc. | 95.12 Million USD | -2761.371% |
| Rezolute, Inc. | 11.73 Million USD | -23095.296% |
| Clene Inc. | 38.95 Million USD | -6887.59% |
| Indaptus Therapeutics, Inc. | 2.84 Million USD | -95487.382% |
| BeyondSpring Inc. | 48.26 Million USD | -5538.683% |
| Synlogic, Inc. | 32.89 Million USD | -8174.011% |
| Allarity Therapeutics, Inc. | 14.61 Million USD | -18525.443% |
| Phio Pharmaceuticals Corp. | 1.63 Million USD | -166468.911% |
| Peak Bio, Inc. | 20.75 Million USD | -13014.674% |
| Werewolf Therapeutics, Inc. | 63.45 Million USD | -4188.968% |
| Krystal Biotech, Inc. | 39.71 Million USD | -6753.341% |
| Karyopharm Therapeutics Inc. | 376.64 Million USD | -622.628% |
| SpringWorks Therapeutics, Inc. | 99.56 Million USD | -2633.517% |
| Lipella Pharmaceuticals Inc. | 432.72 Thousand USD | -628874.455% |
| MannKind Corporation | 721.36 Million USD | -277.303% |
| Ikena Oncology, Inc. | 22.33 Million USD | -12085.968% |
| Cyclerion Therapeutics, Inc. | 2.08 Million USD | -130376.318% |
| Gyre Therapeutics, Inc. | 102.59 Million USD | -2553.023% |
| Gossamer Bio, Inc. | 249.14 Million USD | -992.422% |
| CohBar, Inc. | 1.03 Million USD | -263216.171% |
| Cognition Therapeutics, Inc. | 10.68 Million USD | -25362.962% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -14188.828% |
| Legend Biotech Corporation | 589.93 Million USD | -361.364% |
| Mural Oncology plc | 37.92 Million USD | -7076.06% |
| Biora Therapeutics, Inc. | 132.63 Million USD | -1952.034% |
| PaxMedica, Inc. Common Stock | 2.29 Million USD | -118477.008% |
| Disc Medicine, Inc. | 22.87 Million USD | -11798.299% |
| Champions Oncology, Inc. | 28.03 Million USD | -9608.35% |
| REGENXBIO Inc. | 262.22 Million USD | -937.927% |
| Ensysce Biosciences, Inc. | 3.35 Million USD | -80919.673% |
| Anavex Life Sciences Corp. | 12.53 Million USD | -21614.824% |
| Cellectar Biosciences, Inc. | 13.43 Million USD | -20163.636% |
| Edgewise Therapeutics, Inc. | 21.2 Million USD | -12735.35% |
| Vaxart, Inc. | 34.02 Million USD | -7899.224% |
| PharmaCyte Biotech, Inc. | 20.38 Million USD | -13248.868% |
| Aldeyra Therapeutics, Inc. | 28.53 Million USD | -9439.28% |
| Cellectis S.A. | 249.57 Million USD | -990.548% |
| Longeveron Inc. | 5.33 Million USD | -50897.489% |
| Repare Therapeutics Inc. | 41.81 Million USD | -6408.372% |
| Sarepta Therapeutics, Inc. | 2.4 Billion USD | -13.159% |
| Inozyme Pharma, Inc. | 60.36 Million USD | -4408.574% |
| Revolution Medicines, Inc. | 262.39 Million USD | -937.259% |
| Nymox Pharmaceutical Corporation | 2.1 Million USD | -129075.89% |
| Third Harmonic Bio, Inc. | 8.62 Million USD | -31452.701% |
| ArriVent BioPharma, Inc. Common Stock | 11.8 Million USD | -22963.605% |
| AN2 Therapeutics, Inc. | 14.04 Million USD | -19281.443% |
| Anixa Biosciences, Inc. | 2.15 Million USD | -126433.519% |
| Vertex Pharmaceuticals Incorporated | 5.14 Billion USD | 47.149% |
| Denali Therapeutics Inc. | 122.96 Million USD | -2113.459% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -48809.036% |
| Veru Inc. | 32.81 Million USD | -8194.762% |
| Corvus Pharmaceuticals, Inc. | 6.86 Million USD | -39523.468% |
| Cingulate Inc. | 10.36 Million USD | -26169.39% |
| Passage Bio, Inc. | 39.26 Million USD | -6832.24% |
| Context Therapeutics Inc. | 4.19 Million USD | -64831.323% |
| Exicure, Inc. | 8.54 Million USD | -31736.893% |
| Day One Biopharmaceuticals, Inc. | 29.5 Million USD | -9123.722% |
| Oramed Pharmaceuticals Inc. | 10.48 Million USD | -25855.903% |
| Scinai Immunotherapeutics Ltd. | 22.04 Million USD | -12248.514% |
| Rhythm Pharmaceuticals, Inc. | 162.98 Million USD | -1569.92% |
| Nuvalent, Inc. | 31.82 Million USD | -8452.732% |
| ABVC BioPharma, Inc. | 6.36 Million USD | -42683.646% |
| Carisma Therapeutics, Inc. | 63.02 Million USD | -4218.708% |
| Unicycive Therapeutics, Inc. | 18 Million USD | -15020.756% |
| OmniAb, Inc. | 87.4 Million USD | -3014.114% |
| Anew Medical, Inc. | 8.24 Million USD | -32923.567% |
| Fennec Pharmaceuticals Inc. | 38.28 Million USD | -7008.384% |
| Lipocine Inc. | 2.63 Million USD | -103324.001% |
| Lexeo Therapeutics, Inc. Common Stock | 26.27 Million USD | -10259.836% |
| Nautilus Biotechnology, Inc. | 40.21 Million USD | -6668.467% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -10116.032% |
| G1 Therapeutics, Inc. | 86.15 Million USD | -3059.152% |
| Bellerophon Therapeutics, Inc. | 5.4 Million USD | -50293.186% |
| Sage Therapeutics, Inc. | 82.74 Million USD | -3189.226% |
| Ocugen, Inc. | 23.98 Million USD | -11248.605% |
| Mind Medicine (MindMed) Inc. | 46.4 Million USD | -5764.926% |
| Q32 Bio Inc. | 233.12 Million USD | -1067.486% |
| Brainstorm Cell Therapeutics Inc. | 9.06 Million USD | -29921.355% |
| Alumis Inc. Common Stock | 53.5 Million USD | -4987.167% |
| Equillium, Inc. | 27.95 Million USD | -9635.437% |
| Kyverna Therapeutics, Inc. | 206.59 Million USD | -1217.445% |
| Coya Therapeutics, Inc. | 5.62 Million USD | -48272.1% |
| CNS Pharmaceuticals, Inc. | 6.13 Million USD | -44278.774% |
| Galera Therapeutics, Inc. | 157.32 Million USD | -1629.998% |
| Evelo Biosciences, Inc. | 69.43 Million USD | -3819.946% |
| Comera Life Sciences Holdings, Inc. | 9.97 Million USD | -27187.76% |
| Dominari Holdings Inc. | 4.63 Million USD | -58621.381% |
| Edesa Biotech, Inc. | 1.84 Million USD | -147688.951% |
| vTv Therapeutics Inc. | 29.56 Million USD | -9105.317% |
| Bio-Techne Corporation | 744.34 Million USD | -265.658% |
| Agios Pharmaceuticals, Inc. | 126.09 Million USD | -2058.412% |
| Harmony Biosciences Holdings, Inc. | 344.45 Million USD | -690.155% |
| Prelude Therapeutics Incorporated | 40.57 Million USD | -6607.914% |
| Candel Therapeutics, Inc. | 28.95 Million USD | -9299.233% |
| iTeos Therapeutics, Inc. | 92.36 Million USD | -2846.877% |
| Nkarta, Inc. | 105.6 Million USD | -2477.402% |
| BioCardia, Inc. | 4.59 Million USD | -59197.081% |
| Iterum Therapeutics plc | 32.66 Million USD | -8233.035% |